全文获取类型
收费全文 | 6380篇 |
免费 | 350篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 151篇 |
妇产科学 | 127篇 |
基础医学 | 879篇 |
口腔科学 | 241篇 |
临床医学 | 464篇 |
内科学 | 1515篇 |
皮肤病学 | 415篇 |
神经病学 | 523篇 |
特种医学 | 152篇 |
外科学 | 673篇 |
综合类 | 15篇 |
预防医学 | 235篇 |
眼科学 | 127篇 |
药学 | 527篇 |
中国医学 | 18篇 |
肿瘤学 | 651篇 |
出版年
2023年 | 38篇 |
2022年 | 48篇 |
2021年 | 140篇 |
2020年 | 79篇 |
2019年 | 120篇 |
2018年 | 148篇 |
2017年 | 132篇 |
2016年 | 150篇 |
2015年 | 160篇 |
2014年 | 185篇 |
2013年 | 233篇 |
2012年 | 366篇 |
2011年 | 406篇 |
2010年 | 222篇 |
2009年 | 206篇 |
2008年 | 382篇 |
2007年 | 357篇 |
2006年 | 369篇 |
2005年 | 380篇 |
2004年 | 394篇 |
2003年 | 357篇 |
2002年 | 363篇 |
2001年 | 114篇 |
2000年 | 113篇 |
1999年 | 106篇 |
1998年 | 64篇 |
1997年 | 55篇 |
1996年 | 49篇 |
1995年 | 43篇 |
1994年 | 41篇 |
1993年 | 37篇 |
1992年 | 77篇 |
1991年 | 83篇 |
1990年 | 74篇 |
1989年 | 68篇 |
1988年 | 64篇 |
1987年 | 69篇 |
1986年 | 68篇 |
1985年 | 54篇 |
1984年 | 38篇 |
1983年 | 35篇 |
1982年 | 25篇 |
1981年 | 25篇 |
1980年 | 17篇 |
1979年 | 35篇 |
1978年 | 17篇 |
1972年 | 22篇 |
1970年 | 17篇 |
1969年 | 19篇 |
1968年 | 16篇 |
排序方式: 共有6766条查询结果,搜索用时 500 毫秒
81.
82.
Thrombocytosis in preterm infants: a possible involvement of thrombopoietin receptor gene expression 总被引:2,自引:0,他引:2
Nakayama H Ihara K Hikino S Yamamoto J Nagatomo T Takemoto M Hara T 《Journal of molecular medicine (Berlin, Germany)》2005,83(4):316-320
Transient thrombocytosis is commonly observed in preterm infants after birth, but its physiological mechanism is still unknown. To understand the mechanism of the transient thrombocytosis in preterm infants we firstly evaluated a correlation between platelet counts and thrombopoietin (TPO) levels in preterm infants and next c-mpl mRNA levels on platelets in healthy preterm infants longitudinally during a half-year of life. The mean platelet counts in 45 very low birth weight infants (mean gestational age 27.4±1.8 weeks, mean birth weight 1047±249 g) was 230±71×109/l just after birth and thereafter gradually increased to 579±178×109/l by 5 weeks of age. The platelet counts continued this level for about next 8 weeks. Serum TPO levels soon after birth and at 1 month of age were significantly higher than those at the age of 2–6 months. There was a significant negative correlation between platelet counts and serum TPO values. The c-mpl expression levels on platelets at birth and at 1 month of age tended to be lower than those on platelets from adults, and the c-mpl levels gradually increased through 6 months of age, although they were still lower than those of adults. Our results suggest that low expression of TPO receptor on platelets until 1 month after birth cause a decreased TPO clearance and keep a high level of free TPO in blood, thereby promoting platelet production from megakaryocytes or their progenitors in bone marrow, resulting in the subsequent thrombocytosis in preterm infants. 相似文献
83.
Tatsuro Inoue Keisuke Maeda Ayano Nagano Akio Shimizu Junko Ueshima Kenta Murotani Keisuke Sato Kazuki Hotta Shinichiro Morishita Atsuhiro Tsubaki 《Nutrients》2021,13(2)
Osteopenia/osteoporosis and sarcopenia are common geriatric diseases among older adults and harm activities of daily living (ADL) and quality of life (QOL). Osteosarcopenia is a unique syndrome that is a concomitant of both osteopenia/osteoporosis and sarcopenia. This review aimed to summarize the related factors and clinical outcomes of osteosarcopenia to facilitate understanding, evaluation, prevention, treatment, and further research on osteosarcopenia. We searched the literature to include meta-analyses, reviews, and clinical trials. The prevalence of osteosarcopenia among community-dwelling older adults is significantly higher in female (up to 64.3%) compared to male (8–11%). Osteosarcopenia is a risk factor for death, fractures, and falls based on longitudinal studies. However, the associations between osteosarcopenia and many other factors have been derived based on cross-sectional studies, so the causal relationship is not clear. Few studies of osteosarcopenia in hospitals have been conducted. Osteosarcopenia is a new concept and has not yet been fully researched its relationship to clinical outcomes. Longitudinal studies and high-quality interventional studies are warranted in the future. 相似文献
84.
Junko Ueshima Ryo Momosaki Akio Shimizu Keiko Motokawa Mika Sonoi Yuka Shirai Chiharu Uno Yoji Kokura Midori Shimizu Ai Nishiyama Daisuke Moriyama Kaori Yamamoto Kotomi Sakai 《Nutrients》2021,13(3)
Malnutrition negatively affects the quality of life of patients with dysphagia. Despite the need for nutritional status assessment in patients with dysphagia, standard, effective nutritional assessments are not yet available, and the identification of optimal nutritional assessment items for patients with dysphagia is inadequate. We conducted a scoping review of the use of nutritional assessment items in adult patients with oropharyngeal and esophageal dysphagia. The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases were searched to identify articles published in English within the last 30 years. Twenty-two studies met the inclusion criteria. Seven nutritional assessment categories were identified: body mass index (BMI), nutritional screening tool, anthropometric measurements, body composition, dietary assessment, blood biomarkers, and other. BMI and albumin were more commonly assessed in adults. The Global Leadership Initiative on Malnutrition (GLIM), defining new diagnostic criteria for malnutrition, includes the categories of BMI, nutritional screening tool, anthropometric measurements, body composition, and dietary assessment as its required components, but not the blood biomarkers and the “other” categories. We recommend assessing nutritional status, including GLIM criteria, in adult patients with dysphagia. This would standardize nutritional assessments in patients with dysphagia and allow future global comparisons of the prevalence and outcomes of malnutrition, as well as of appropriate interventions. 相似文献
85.
86.
Kobayashi Mana Kageyama Yutaro Ando Takashi Sakamoto Junko Kimura Shohji 《Clinical and experimental nephrology》2021,25(8):854-864
Clinical and Experimental Nephrology - Rituximab is conditionally approved in Japan for use in patients with refractory nephrotic syndrome. To meet the conditions of approval, an all-case... 相似文献
87.
Ishihara Hiroki Fukuda Hironori Tachibana Hidekazu Yoshida Kazuhiko Kobayashi Hirohito Takagi Toshio Iizuka Junpei Ishida Hideki Nagashima Yoji Kondo Tsunenori Tanabe Kazunari 《Clinical and experimental nephrology》2021,25(6):674-682
Clinical and Experimental Nephrology - The data regarding oncological outcome in advanced renal cell carcinoma (RCC) arising in end-stage renal disease (ESRD) are limited. Patients diagnosed with... 相似文献
88.
Yuko Kaneyasu Hisaya Fujiwara Tetsuo Nishimura Hideyuki Sakurai Tomoko Kazumoto Hitoshi Ikushima Takashi Uno Sunao Tokumaru Yoko Harima Hiromichi Gomi Takafumi Toita Midori Kita Shin-ei Noda Takeo Takahashi Shingo Kato Ayako Ohkawa Akiko Tozawa-Ono Hiroki Ushijima Yoko Hasumi Yasuyuki Hirashima Yuzuru Niibe Tomio Nakagawa Tomoyuki Akita Junko Tanaka Tatsuya Ohno the Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group 《Journal of radiation research》2021,62(2):269
This study aimed to research the post-treatment quality of life (QOL) between radiotherapy (RT)- and operation (OP)-treated early cervical cancer survivors, using separate questionnaires for physicians and patients. We administered an observational questionnaire to patients aged 20–70 years old with Stages IB1–IIB cervical cancer who had undergone RT or OP and without recurrence as outpatients for ≥6 months after treatment. We divided 100 registered patients equally into two treatment groups (n = 50 each). The average age was 53 and 44 years in the RT and OP groups, respectively. The RT group included 34 and 66% Stage I and II patients, respectively, whereas the OP group included 66 and 34% Stage I and II patients, respectively. The OP group included 58% of patients with postoperative RT. Combination chemotherapy was performed in 84 and 48% of patients in the RT and OP groups, respectively. On the physicians’ questionnaire, we observed significant differences in bone marrow suppression (RT) and leg edema (OP). On the patients’ questionnaire, significantly more patients had dysuria and leg edema in the OP group than in the RT group, and severe (Score 4–5) leg edema was significantly higher in the post-operative RT group than in the OP only group. The frequency of sexual intercourse decreased after treatment in both groups. On the patients’ questionnaire, there were no significant differences between the two groups regarding sexual activity. These findings are useful to patients and physicians for shared decision-making in treatment choices. The guidance of everyday life and health information including sexual life after treatment is important. 相似文献
89.
Junko Adachi Takeaki Naito Yasuhiro Ueno Yumi Ogawa Ichiya Ninomiya Yoshitsugu Tatsuno 《Archives of toxicology》1993,67(4):284-289
Peak E substance, 1,1-ethylidenebis[tryptophan], a contaminant found inl-tryptophan tablets, has been suggested as a causative agent for eosinophilia-myalgia syndrome (EMS). Peak E substance (50 mg/kg) was administered perorally to Wistar rats to determine its metabolism and distribution. A purification procedure using Bond Elut C8 cartridges followed by HPLC was developed for the determination of peak E substance. The plasma concentration of peak E substance was 136 ng/ml at 1 h, and urinary excretion was 717 ng at 5 h and 10342 ng for 5–24 h, showing slow excretion of peak E substance into urine. The amount of peak E substance in the contents of the large intestine at 5 h, however, was 3136 g, much greater than urinary excretion for 24 h, indicating considerable transfer of peak E substance to large intestine without decomposition by gastric fluid in the stomach. We have detected for the first time not only the occurrence of peak E substance in plasma and urine, but also 1-methyl-tetrahydro--carboline-3-carboxylic acid (MTCA) in blood and organs of rats treated with peak E substance, thereby suggesting MTCA as one of the the metabolites of peak E substance. The amount of MTCA in the contents of the large intestine as well as in urine of rats treated with peak E substance was significantly greater than inl-tryptophantreated rats (50 mg/kg p.o.), demonstrating that MTCA was more readily produced from peak E substance than froml-tryptophan. Finally, we propose acetaldehydeinduced production of MTCA from peak E substance. 相似文献
90.
1-Methyl-tetrahydro--carboline-3-carboxylic acid (MTCA) may cause eosinophilia-myalgia syndrome (EMS) associated with ingestion ofl-tryptophan. The distribution and excretion of MTCA were studied in rats which had received perorally a single 1.6 mg/kg dose of MTCA. MTCA concentrations in blood, kidney, liver, brain, heart, spleen, lung and gastrocnemius muscle were measured by HPLC combined with fluorometric detection. The concentration of MTCA in each organ reached a maximum at 1 h and then gradually declined. However, a significant level of MTCA still remained at 5 h, when 52% of ingested MTCA remained in the contents of the large intestine. Twenty-nine percent of the ingested MTCA was excreted in urine over the course of 24 h. A higher dose (10 mg/kg) of MTCA resulted in significant elevations in the concentrations and amounts of MTCA in the various organs. In addition, chronic treatment with a 10 mg/kg dose of MTCA for 6 weeks further increased the concentrations and amounts of MTCA in each organ. However, no histological changes were observed in any of the organs after chronic treatment. This is the first report which demonstrates accumulation of MTCA in the blood and various organs, including muscle, of rats. 相似文献